Carolin Ertl, Theresa Ruf, Dirk Mentzer, Mingzi Kong, Rafaela Kramer, Michael von Bergwelt-Baildon, Marion Subklewe, Dirk Tomsitz, Paolo A Ascierto, Reinhard Dummer, Helen Gogas, Celeste Lebbé, Georgina V Long, Grant McArthur, Tomas G Neilan, Antoni Ribas, Caroline Robert, Dirk Schadendorf, Lisa Zimmer, Thomas Eigentler, Stephan Grabbe, Andrea Forschner, Katharina C Kähler, Valeria Milani, Claudia Pföhler, Jessica Hassel, Ralf Gutzmer, Carmen Loquai, Bertrand Routy, Andrew J S Furness, Christian Blank, Jedd D Wolchok, Lars E French, Axel Hauschild, Lucie Heinzerling
BACKGROUND: Immunotherapies such as immune checkpoint inhibitors (ICI) are effective in multiple tumor entities but induce a plethora of side effects. Comprehensive real-world analyses are essential to identify new signals, characterize diagnostic features, enable risk assessment, determine pathomechanisms, assess effectiveness of side effect management and compare tumor outcomes. METHODS: The international online `Side-Effect Registry Immuno-Oncology´ (SERIO; www...
March 2024: European Journal of Cancer